IRONWOOD PHARMACEUTICALS INC - 10-Q Filing

Ironwood Pharmaceuticals reports Q3 2026 financial results including royalty income from AbbVie collaborative arrangements and updates on convertible senior notes.

SEC EDGAR ·

Tickers: $IRWD

Read the full article at SEC EDGAR

More Regulatory news